Member Info for Nlgb

Rating is Hold with a £47 price target…? 🤔

Only slightly incompatible but we’ll have the £47

Well done DB!

Have you sent the sequel this afternoon? Just an ordinary Wednesday. We like to see more of it!

Good. Thks

US shutdown may affect govt agencies like the FDA and The Times just reports that Jefferies predict it could be longer than usual. Let’s hope that impact will be minimal.

Sorry, if your 500k..etc

Well, you seem to have had an impact.. double digit even.. 😎

Java,

If you’re 500k is the right number, that is not roughly 30% but 0.03%.

That 99p target is just as an “amuse bouche”..

Touk,

“Later this month” = pretty soon 😉

Bella,

It seems to me that the 1 (also added in the text after faridoxorubicin) is indicating a footnote but badly presented both in the text as in the footnote..

Another yoyo day it seems but the vast number of unknown transactions, including for 0 shares (!) points to some sort of “funny”stuff going on behind the scenes imho.

LDA,

“Tuesday could be the most important update in the history of Avacta”

You finally will get your answers.. thank you for insisting 😉

Yes Wyn, I assumed and probably was right.. not important.

Everybody has his/her own strategy and responsibility. By the way, why don’t you use the buy/hold/sell options. Like that you don’t have to write long messages and we all can benefit from your well thought through strategy. It would be the best way to protect us all from doing silly things with our money.

Enjoy your weekend

I think he was sarcastic Wyn..🤓

Must add that DT’s statements over the last days have had their impact: pharma big and small are being battered.

Volatility is laughable, even with this smallcap. PI’s panick sells. Hold tight and sit back.

Company demonstrates pro-active forward looking management with results remaining almost in line with last year’s despite the setbacks. Very positive in my opinion.

@ Alde,

These deals are not signed overnight and will take weeks to materialize. Lawyers and Gov officials will have to go through it and agree on all points. Other countries with similar legal structures will jump on this.

One question is how the FDA will see this: a carefully planned and controlled trial on one side but a (commercial) roll out already underway. Does anybody know of similar situations and how they panned out?

@JSB

Sorry, you’re talking about Bloom Energy, my bad

@JSB

I see a mcap of 260m or do I misread your post?